ro 31-8830 has been researched along with ro 31-8425 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bit, RA; Davis, PD; Elliott, LH; Harris, W; Hill, CH; Keech, E; Kumar, H; Lawton, G; Maw, A; Nixon, JS | 1 |
| Bishop, J; Bradshaw, D; Davis, PD; Elliott, LH; Hill, CH; Kumar, H; Lawton, G; Lewis, EJ; Mulqueen, M; Nixon, JS | 1 |
2 other study(ies) available for ro 31-8830 and ro 31-8425
| Article | Year |
|---|---|
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.
Topics: Alkaloids; Animals; Humans; Maleimides; Mice; Models, Molecular; Molecular Conformation; Protein Kinase C; Rabbits; Rats; Staurosporine; Stereoisomerism; Structure-Activity Relationship | 1993 |
Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Female; Indoles; Male; Maleimides; Mice; Phorbol Esters; Protein Kinase C; Rats | 1991 |